Septerna, Inc. Common Stock (SEPN) stock news · rev $46.0M
Septerna, Inc. Common Stock (SEPN) is a biotechnology company listed on NASDAQ.
This SEPN news page leads with what Septerna, Inc. Common Stock filed — not a scraped headline mill.
No cached 8-K sentence for SEPN yet. We will not pad this page with generic market recap.
Latest reported SEPN revenue for 2025-12-31 was $46.0M. Net income was -$48.9M. Revenue was up 4174.5% from 2024-12-31 to 2025-12-31. SEPN currently screens at market cap $1.61B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SEPN stock page; for the tape open the quote page.
SEPN stock news FAQ
What are SEPN's latest revenue and net income?
Latest cached Septerna, Inc. Common Stock (SEPN) revenue for Dec 31, 2025 was $46.0M. Net income was -$48.9M. Statements: https://lician.com/financials/sepn
How did SEPN revenue change from the prior cached period?
Cached Septerna, Inc. Common Stock (SEPN) revenue was up 4174.5% from $1.1M (Dec 31, 2024) to $46.0M (Dec 31, 2025). Statements: https://lician.com/financials/sepn
What is SEPN's market cap?
Septerna, Inc. Common Stock (SEPN) market cap is $1.61B on the latest cached fundamentals snapshot.
What kind of company is SEPN?
Septerna, Inc. Common Stock (SEPN) is a biotechnology company listed on NASDAQ.
Where is SEPN stock news listed?
Cached stock news for Septerna, Inc. Common Stock (SEPN) is listed at https://lician.com/news/sepn. Filings: https://lician.com/sec/sepn
Not investment advice.